Akero Therapeutics is a U.S.-based biopharmaceutical company focused on developing therapies for serious metabolic diseases, including liver-related conditions. Its activities center on clinical research and drug development.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!